2016 30 SEPTEMBER 2017 (THB mn) % out of total assets (THB mn) % out of total assets Cash & cash equivalents and Current investments 484 29.7% 203 10.3% Trade & other receivables 276 16.9% 295 14.9
(Decreased) % Assets Current assets Cash and cash equivalents 107.23 35.22 72.01 204.46 Trade and other receivables 202.32 208.40 (6.08) (2.92) Unbilled receivables 437.14 273.72 163.42 59.70 Inventories 22.81
benefits for all stakeholders. The company has a policy to manage costs and resources of the company to maximize efficiency, including managing cash flow sufficient for business operations in the current
million including THB 5,413.60 million (31.10% of total assets) in current assets, THB 8,118.77 million (46.64% of total assets) in property, plant and equipment (PP&E), THB 2,627.04 million (15.09% of
million, decreased by Baht 201 million from year ended 2017 which has total asset Baht 32,172 million. Total assets separate into current assets amounted to Baht 6,029 million, increased 13% from year 2017
) %YoY (Unit: Million Baht) Amount % Amount % Cash and cash equivalents 99.84 3.78% 153.04 5.21% 53.19 53.28% Trade and other current receivables 273.09 10.33% 352.21 11.99% 79.13 28.97% Inventories
improvement. Other Transaction In Year 2018, the company recorded Baht 34.0 million from gain on changes in fair value less costs to sell biological asset, gain on sales deposits from land Baht 22.2 million and
cost to sale of biological assets. Financial Cost Financial cost in Quarter 2/2019 was Baht 8.5 Million decreased by Baht 1.3 Million or 13.1% from Q2/2018 mainly from bank loan repayment in 2018. Net
Transaction In Quarter 2/2018, the company recorded Baht 22.2 million from gain on sales of deposits for land, Baht 3.9 million from gain on changes in fair value less costs to sell biological asset and Baht
and internal control of subsidiaries improvement. Other Transaction In Quarter 3/2018, the company recorded Baht 4.0 million from gain on changes in fair value less costs to sell biological asset and